Background & Aims Radiofrequency ablation (RFA) with or without endoscopic mucosal
resection (EMR) is routinely used for treatment of Barrett's esophagus with dysplasia …

Background: Esophageal cancer (EC) occurs commonly, especially in Asia, and is the sixth
leading cause of cancer deaths worldwide. Recently, great progress has been made in …

Objective Focal endoscopic resection (ER) followed by radiofrequency ablation (RFA) safely
and effectively eradicates Barrett's oesophagus (BO) containing high-grade dysplasia (HGD) …

Objectives: Recent data suggest that effective control of gastroesophageal reflux improves
outcomes associated with endoscopic eradication therapy (EET) for Barrett's esophagus …

Background Conflicting data exist with regard to recurrence rates of intestinal metaplasia
(IM) and dysplasia after achieving complete eradication of intestinal metaplasia (CE-IM) in …

Background and Aims The management of early neoplasia in Barrett's esophagus (BE)
requires endoscopic resection of visible lesions, followed by radiofrequency ablation (RFA) …

Background and objective Focal endoscopic mucosal resection (EMR) of visible
intraepithelial lesions arising within Barrett's esophagus (BE) may miss synchronous lesions …

Background & Aims Radiofrequency ablation (RFA) is the most common treatment for flat
Barrett's esophagus (BE), but reasons for varying outcomes are poorly understood. A …

Radiofrequency ablation (RFA) is safe and effective for eradication of Barrett's esophagus
after endoscopic resection (ER) of neoplasia. Widespread ER, however, is likely to induce …

Research and clinical experience with the endoscopic therapies for Barrett's esophagus
continue to grow. Proper patient selection and technique are critical for ensuring a good …